Header Logo

John Segreti

Concepts (237)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Anti-Bacterial Agents
24
2020
401
3.280
Why?
Daptomycin
9
2013
13
1.710
Why?
Staphylococcal Infections
6
2018
175
1.320
Why?
Prosthesis-Related Infections
7
2020
214
1.180
Why?
Cross Infection
5
2023
304
1.060
Why?
Anti-Infective Agents
10
2005
63
0.960
Why?
Gram-Positive Bacterial Infections
5
2013
58
0.930
Why?
Clostridium Infections
1
2023
19
0.890
Why?
Communicable Diseases
1
2023
24
0.890
Why?
Bacterial Infections
5
2011
66
0.890
Why?
Staphylococcus aureus
7
2018
84
0.810
Why?
Infection Control
3
2018
174
0.770
Why?
Catheterization, Central Venous
2
2011
42
0.680
Why?
Fluoroquinolones
7
2011
25
0.640
Why?
Skin Diseases, Bacterial
3
2018
5
0.640
Why?
Surgical Wound Infection
2
2017
98
0.630
Why?
Sepsis
3
2011
147
0.630
Why?
Bacteria
4
2011
76
0.620
Why?
Soft Tissue Infections
3
2018
28
0.620
Why?
Bacteremia
2
2010
117
0.590
Why?
Enterococcus
4
2013
57
0.570
Why?
Methicillin-Resistant Staphylococcus aureus
2
2016
124
0.540
Why?
Humans
50
2023
29852
0.530
Why?
Arthroplasty, Replacement
1
2017
149
0.510
Why?
Endocarditis, Bacterial
2
2006
10
0.450
Why?
Microbial Sensitivity Tests
12
2018
110
0.440
Why?
Oxazolidinones
2
2010
6
0.440
Why?
Acetamides
2
2010
7
0.440
Why?
Vancomycin Resistance
2
2010
29
0.430
Why?
Quinolones
5
1991
22
0.380
Why?
Methicillin Resistance
2
2008
31
0.370
Why?
Retrospective Studies
11
2023
3325
0.340
Why?
Antibiotic Prophylaxis
3
2016
37
0.330
Why?
Catheters, Indwelling
1
2008
26
0.310
Why?
Diagnostic Tests, Routine
2
2019
16
0.310
Why?
Hospitals, University
1
2008
40
0.310
Why?
Attitude of Health Personnel
1
2009
149
0.310
Why?
Benchmarking
1
2008
42
0.310
Why?
Pneumonia, Bacterial
2
2005
10
0.300
Why?
Quality of Health Care
2
2011
138
0.300
Why?
Health Knowledge, Attitudes, Practice
1
2009
193
0.290
Why?
Cefazolin
2
2018
5
0.290
Why?
Chlamydia trachomatis
4
1991
17
0.280
Why?
Gram-Negative Bacterial Infections
2
2007
24
0.280
Why?
United States
6
2017
2346
0.260
Why?
Bone Diseases
1
2005
24
0.260
Why?
Microbiological Techniques
2
2016
9
0.260
Why?
Arthroplasty, Replacement, Knee
3
2020
696
0.260
Why?
Critical Care
1
2008
242
0.260
Why?
Arthroplasty, Replacement, Hip
3
2020
857
0.250
Why?
Ambulatory Care
1
2005
78
0.250
Why?
Infection Control Practitioners
1
2004
2
0.240
Why?
Joint Diseases
1
2005
111
0.240
Why?
Equipment Contamination
1
2004
26
0.240
Why?
Ambulatory Care Facilities
1
2004
37
0.230
Why?
Knee Prosthesis
2
2020
244
0.220
Why?
Hospitals
1
2023
157
0.210
Why?
Treatment Outcome
10
2015
3561
0.210
Why?
Hip Prosthesis
3
2020
569
0.190
Why?
Disease Management
2
2019
122
0.190
Why?
Adult
13
2018
8748
0.180
Why?
Cephalosporins
3
1997
17
0.180
Why?
Orthopedic Fixation Devices
1
1999
24
0.180
Why?
Male
17
2020
15871
0.170
Why?
Heart Valve Prosthesis
1
1999
21
0.170
Why?
Discitis
1
2019
4
0.170
Why?
Surgical Procedures, Operative
1
2019
30
0.170
Why?
Drug Resistance, Bacterial
2
2011
52
0.160
Why?
Genes, Bacterial
1
2018
6
0.160
Why?
Middle Aged
12
2020
9963
0.160
Why?
Carbapenem-Resistant Enterobacteriaceae
1
2018
13
0.160
Why?
Linezolid
2
2010
6
0.160
Why?
Enterobacteriaceae Infections
1
2018
38
0.160
Why?
Carrier State
1
2018
52
0.160
Why?
Fasciitis, Necrotizing
1
2018
4
0.160
Why?
Reoperation
2
2020
927
0.150
Why?
Aged
10
2020
9621
0.150
Why?
Meningitis, Bacterial
1
1996
8
0.140
Why?
Mass Screening
1
2018
180
0.140
Why?
Legionella pneumophila
1
1996
1
0.140
Why?
Clarithromycin
1
1996
5
0.140
Why?
Erythromycin
1
1996
10
0.140
Why?
Azithromycin
1
1996
4
0.140
Why?
Prosthesis Failure
1
2020
530
0.140
Why?
Female
13
2020
16430
0.130
Why?
Chicago
4
2018
867
0.130
Why?
Oxacillin
1
2015
2
0.130
Why?
Arthroplasty
1
2016
138
0.130
Why?
Methicillin
1
2015
6
0.130
Why?
Drug Hypersensitivity
1
1995
16
0.130
Why?
Sexually Transmitted Diseases, Bacterial
2
1991
3
0.130
Why?
Aged, 80 and over
6
2018
4930
0.130
Why?
Diarrhea
3
1990
47
0.130
Why?
Ceftizoxime
1
1994
2
0.120
Why?
Neisseria gonorrhoeae
2
1991
7
0.120
Why?
Cyclic N-Oxides
1
1993
5
0.110
Why?
Campylobacter
1
1993
8
0.110
Why?
Endocarditis
1
2013
9
0.110
Why?
Quinoxalines
1
1993
11
0.110
Why?
Enterococcus faecalis
1
2013
7
0.110
Why?
Enterococcus faecium
1
2013
15
0.110
Why?
Drainage
1
2013
50
0.110
Why?
Cohort Studies
3
2015
1953
0.100
Why?
Uterine Cervicitis
1
1991
2
0.100
Why?
Urethritis
1
1991
2
0.100
Why?
Aza Compounds
1
2011
1
0.100
Why?
Administration, Ophthalmic
1
2011
1
0.100
Why?
Azepines
1
2011
7
0.100
Why?
Quinolines
1
2011
16
0.100
Why?
4-Quinolones
4
1995
6
0.100
Why?
Serratia marcescens
1
2010
11
0.090
Why?
Serratia Infections
1
2010
10
0.090
Why?
Risk Reduction Behavior
1
2011
55
0.090
Why?
Naphthyridines
1
1990
6
0.090
Why?
Cost-Benefit Analysis
1
2011
143
0.090
Why?
Health Care Costs
1
2011
70
0.090
Why?
Data Interpretation, Statistical
1
2010
98
0.090
Why?
Illinois
1
2011
241
0.090
Why?
Disease Outbreaks
1
2010
89
0.090
Why?
Models, Biological
1
2011
347
0.090
Why?
Multivariate Analysis
1
2010
332
0.090
Why?
Tetracyclines
1
1989
3
0.090
Why?
Rifampin
1
1989
7
0.080
Why?
Drug Resistance, Microbial
3
1996
96
0.080
Why?
Minocycline
1
1989
8
0.080
Why?
Shock, Septic
1
1989
62
0.080
Why?
Time Factors
4
2020
1641
0.080
Why?
Neurocognitive Disorders
1
1988
19
0.080
Why?
Algorithms
1
2010
401
0.080
Why?
Acquired Immunodeficiency Syndrome
1
1988
92
0.080
Why?
Guideline Adherence
1
2008
67
0.080
Why?
Quality Indicators, Health Care
1
2008
39
0.080
Why?
Product Surveillance, Postmarketing
1
2007
17
0.080
Why?
Vancomycin
1
2008
58
0.080
Why?
Skin Diseases, Infectious
1
2007
9
0.080
Why?
Prognosis
1
2010
874
0.070
Why?
Q Fever
1
2006
4
0.070
Why?
Travel
1
2006
14
0.070
Why?
Community-Acquired Infections
2
2005
78
0.070
Why?
Registries
1
2007
191
0.070
Why?
Tobramycin
1
2005
10
0.070
Why?
Calcium Sulfate
1
2005
20
0.060
Why?
Bone Substitutes
1
2005
26
0.060
Why?
Dose-Response Relationship, Drug
3
2011
456
0.060
Why?
Animals
2
2011
4637
0.060
Why?
Humerus
1
2005
101
0.060
Why?
Joint Commission on Accreditation of Healthcare Organizations
1
2004
5
0.060
Why?
Risk Factors
1
2011
2467
0.060
Why?
Doxycycline
3
2006
20
0.060
Why?
Bone Transplantation
1
2005
227
0.050
Why?
Practice Guidelines as Topic
1
2005
334
0.050
Why?
Administration, Oral
2
2020
144
0.050
Why?
Ciprofloxacin
3
1993
28
0.050
Why?
Gram-Negative Bacteria
2
2007
37
0.050
Why?
Diagnosis, Differential
2
2006
399
0.050
Why?
Follow-Up Studies
3
2005
1859
0.050
Why?
Ofloxacin
2
1997
5
0.040
Why?
Bacterial Load
1
2018
13
0.040
Why?
Rectum
1
2018
61
0.040
Why?
Gas Gangrene
1
2018
1
0.040
Why?
Leukocidins
1
2018
2
0.040
Why?
Dermatomycoses
1
2018
3
0.040
Why?
Exotoxins
1
2018
14
0.040
Why?
Pyomyositis
1
2018
5
0.040
Why?
Substance Abuse, Intravenous
1
2018
12
0.040
Why?
Administration, Intravenous
1
2018
28
0.040
Why?
Tertiary Care Centers
1
2018
67
0.040
Why?
Immunoglobulins
1
2018
29
0.040
Why?
Bacterial Toxins
1
2018
21
0.040
Why?
Chronic Disease
1
2020
508
0.040
Why?
Immunocompromised Host
1
2018
45
0.040
Why?
Prodrugs
1
1997
4
0.040
Why?
Ceftriaxone
1
1997
5
0.040
Why?
Cefuroxime
1
1997
2
0.040
Why?
Levofloxacin
1
1997
5
0.040
Why?
Academic Medical Centers
1
2018
142
0.040
Why?
Prevalence
1
2018
494
0.040
Why?
Legionnaires' Disease
1
1996
1
0.040
Why?
Emergencies
1
1996
39
0.030
Why?
Bacteriological Techniques
1
1996
20
0.030
Why?
Campylobacter Infections
2
1993
11
0.030
Why?
Acute Disease
1
1996
225
0.030
Why?
Skin Tests
1
1995
14
0.030
Why?
Listeriosis
1
1995
6
0.030
Why?
Intensive Care Units
1
2018
312
0.030
Why?
Adolescent
2
2018
2334
0.030
Why?
Staphylococcus
1
1995
10
0.030
Why?
Drug Utilization
1
1995
27
0.030
Why?
Arthritis, Infectious
1
1995
58
0.030
Why?
Campylobacter coli
1
1993
2
0.030
Why?
Metronidazole
1
1993
8
0.030
Why?
Borrelia burgdorferi Group
1
1993
6
0.030
Why?
Enterocolitis, Pseudomembranous
1
1993
16
0.030
Why?
Contraindications
1
2013
42
0.030
Why?
Blood
1
2013
25
0.030
Why?
Creatine Kinase
1
2013
33
0.030
Why?
Drug Administration Schedule
1
2013
232
0.030
Why?
Survival Analysis
1
2013
310
0.030
Why?
Osteoarthritis, Hip
1
2013
96
0.030
Why?
Prospective Studies
2
2013
1824
0.030
Why?
Young Adult
1
2018
1969
0.030
Why?
Ureaplasma urealyticum
1
1991
1
0.030
Why?
Mycoplasma
1
1991
4
0.030
Why?
Treponema pallidum
1
1991
4
0.030
Why?
Gonorrhea
1
1991
8
0.030
Why?
Serratia
1
2010
7
0.020
Why?
Syringes
1
2010
11
0.020
Why?
Blood Sedimentation
1
2010
64
0.020
Why?
Biopsy, Fine-Needle
1
2010
51
0.020
Why?
Interviews as Topic
1
2010
130
0.020
Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
1990
7
0.020
Why?
C-Reactive Protein
1
2010
125
0.020
Why?
Diagnostic Imaging
1
2010
90
0.020
Why?
Norfloxacin
1
1989
2
0.020
Why?
Drug Synergism
1
1989
66
0.020
Why?
Hip Joint
1
2013
357
0.020
Why?
Osteoarthritis, Knee
1
2013
382
0.020
Why?
Urinary Tract Infections
1
1989
32
0.020
Why?
Pneumonia
1
1989
67
0.020
Why?
Knee Joint
1
2013
800
0.020
Why?
Coxiella burnetii
1
2006
3
0.020
Why?
Antigens, Bacterial
1
2006
7
0.020
Why?
Australia
1
2006
46
0.020
Why?
Severity of Illness Index
1
2011
1126
0.020
Why?
Drug Implants
1
2005
12
0.020
Why?
Osteomyelitis
1
2005
23
0.020
Why?
Dogs
1
2005
261
0.020
Why?
Radiography
1
2005
678
0.010
Why?
Injections, Intravenous
1
1997
58
0.010
Why?
Drug Therapy, Combination
1
1997
245
0.010
Why?
Macrolides
1
1993
5
0.010
Why?
Kidney Transplantation
1
1995
126
0.010
Why?
Dysentery, Bacillary
1
1990
2
0.010
Why?
Campylobacter fetus
1
1990
4
0.010
Why?
Salmonella Infections
1
1990
3
0.010
Why?
Double-Blind Method
1
1990
522
0.010
Why?
Randomized Controlled Trials as Topic
1
1990
349
0.000
Why?
Segreti's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (237)
Explore
_
Co-Authors (11)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_